+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hormonal Contraceptives Market, by Product, by Hormone, by Age Group, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 195 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5456027
Hormonal contraception is one of the contraceptive methods that act on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception can also cause changes in the uterus, making pregnancy less likely. Based on product, the market is segmented into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal ring and transdermal patches. These are safe and reliable forms of hormonal contraceptives to prevent pregnancy. Hormonal contraception has several potential benefits such as they can reduce the risk of uterine cancer, ovarian cancer, and colon cancer. They generally reduce menstrual (menstrual) blood flow. They can reduce painful periods and are very effective in preventing pregnancy.



Market Dynamics


Increased awareness about the benefits and use of contraceptives is a major factor driving the global hormonal contraceptives market. The ever-increasing global population, particularly in developing economies such as India, Brazil, China and others, is a growing source of concern around the world, necessitating government initiatives such as public awareness campaigns to eliminate or reduce the risk of unwanted pregnancies, abortion risks, and the threat of sexual disorders. For instance, according to data from the World Health Organization (WHO), 16 million girls between the ages of 15 and 19 give birth each year, which represents approximately 11% of all births in the world. To prevent these unintended births, the World Health Organization have launched global awareness programs such as This is your life, this is your future. The London Family Planning Summit urged governments, international agencies and other private sectors to commit to improving the accessibility of voluntary family planning.

Key features of the study:

  • This report provides in-depth analysis of the global hormonal contraceptives market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hormonal contraceptives market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hormonal contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormonal contraceptives market

Detailed Segmentation:


Global Hormonal Contraceptives Market, By Product:

  • Oral Contraceptive Pills
  • Injectable Birth Control
  • Emergency Contraceptive Pills
  • Vaginal Ring
  • Transdermal Patches

Global Hormonal Contraceptives Market, By Hormone:

  • Progestin Only Contraceptive
  • Combined Hormonal Contraceptive

Global Hormonal Contraceptives Market, By Age Group:

  • 15-24 Years
  • 25-34 Years
  • 35-44 Years
  • Above 44 Years

Global Hormonal Contraceptives Market, By End User:

  • Hospitals
  • Homecare
  • Gynecology Centers
  • Clinics
  • Ambulatory Surgical Centers

Global Hormonal Contraceptives Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • The Female Health Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Teva Pharmaceutical Industries Limited
  • Bayer AG
  • Pfizer, Inc.
  • Mylan N.V.
  • Johnson & Johnson
  • Ansell Ltd.
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Church & Dwight, Co., Inc.
  • Afaxys, Inc.
  • Allergan plc.
  • Agile Therapeutics
  • Apothecus Pharmaceutical Corporation.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
Frequently Asked Questions about the Hormonal Contraceptives Market

What is the estimated value of the Hormonal Contraceptives Market?

The Hormonal Contraceptives Market was estimated to be valued at $15232.2 Million in 2021.

What is the growth rate of the Hormonal Contraceptives Market?

The growth rate of the Hormonal Contraceptives Market is 2.9%, with an estimated value of $18577.6 Million by 2028.

What is the forecasted size of the Hormonal Contraceptives Market?

The Hormonal Contraceptives Market is estimated to be worth $18577.6 Million by 2028.

Who are the key companies in the Hormonal Contraceptives Market?

Key companies in the Hormonal Contraceptives Market include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories and Church & Dwight.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Hormone
  • Market Snapshot, By Age Group
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Hormonal Contraceptives Market Insights
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Market Trends
  • Product Launches
  • Key Developments
  • Regulatory Scenario
  • Reimbursement Scenario
  • Merger and Acquisition
  • Epidemiology
  • PEST Analysis
  • SWOT Analysis

4. Global Hormonal Contraceptives Market- COVID-19 Impact Analysis
  • Economic Impact
  • COVID-19 Epidemiology
  • Impact of COVID-19 on supply chain

5. Global Hormonal Contraceptives Market, By Product, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Oral Contraceptive Pills
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Injectable Birth Control
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Emergency Contraceptive Pills
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Vaginal Ring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Transdermal Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

6. Global Hormonal Contraceptives Market, By Hormone, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Progestin Only Contraceptive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Combined Hormonal Contraceptive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Hormonal Contraceptives Market, By Age Group, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • 15-24 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • 25-34 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • 35-44 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Above 44 Years
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

8. Global Hormonal Contraceptives Market, By End User, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Homecare
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • Gynecology Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

9. Global Hormonal Contraceptives Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Region at Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2028, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Snapshot
Company Profiles
  • The Female Health Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Teva Pharmaceutical Industries Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Ansell Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Mayer Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Church & Dwight, Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Afaxys, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Allergan plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Agile Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Apothecus Pharmaceutical Corporation.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Cipla Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

11. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • The Female Health Company
  • Teva Pharmaceutical Industries Limited
  • Bayer AG
  • Pfizer Inc.
  • Mylan N.V.
  • Johnson & Johnson
  • Ansell Ltd.
  • Mayer Laboratories
  • Merck & Co. Inc.
  • Church & Dwight
  • Co. Inc.
  • Afaxys Inc.
  • Allergan plc.
  • Agile Therapeutics
  • Apothecus Pharmaceutical Corporation.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited